首页> 外文期刊>International journal of clinical pharmacology and therapeutics >International Journal of Clinical Pharmacology and Therapeutics: Editorial
【24h】

International Journal of Clinical Pharmacology and Therapeutics: Editorial

机译:国际临床药理学和治疗学杂志:社论

获取原文
获取原文并翻译 | 示例
           

摘要

The Annual Meeting of the Central European Society for Anticancer Drug Research-EWIV (CESAR) was held in Essen from June 28 - 30, 2012. As in the past it attracted scientists from Germany, Switzerland, and Austria active in clinical and pre-clinical drug research.The 2012 Meeting was held under the central topic Combination of new molecular entities in Oncology. The idea was to consider and discuss the different perspectives relevant for the successful development and testing of the combination of new molecules as well as established drugs. Novel drug combinations might provide new options for individualized treatment strategies. The better understanding and further development of drug combinations might allow targeted treatment regimens, improving the therapeutic outcome and to guarantee patient safety.
机译:2012年6月28日至30日,中欧抗癌药物研究中心(EWSAR)年会在埃森举行。与以往一样,它吸引了来自德国,瑞士和奥地利的活跃于临床和临床前研究的科学家药物研究.2012年会议的主题是肿瘤学中的新分子实体的组合。这个想法是要考虑和讨论与成功开发和测试新分子以及已确立药物组合有关的不同观点。新药组合可能为个性化治疗策略提供新的选择。对药物组合的更好的了解和进一步的发展可能允许有针对性的治疗方案,改善治疗效果并保证患者安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号